Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for oral mucositis after BEAM and autologous PBSCT in lymphoma
DRKS00000043Phase 4Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Nov 2008
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of palifermin in Hodgkin lymphoma (HL), follicular lymphoma (FL), Non-Hodgkin Lymphomas excluding Follicular Lymphoma, peripheral T cell lymphomas (PTCL), non-Hodgkin lymphoma (NHL), sponsored by Universitätsklinikum Freiburg. Started Nov 2008; status: completed.
02
Drugs
palifermin
03
Conditions
Hodgkin lymphoma (HL)follicular lymphoma (FL)Non-Hodgkin Lymphomas excluding Follicular Lymphomaperipheral T cell lymphomas (PTCL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on DRKS00000043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000043.